Anavex Life Sciences Corp (AVXL)

[A_Good_Day_2]

I agree... but it is certainly interesting that this statement is very different from the way it has been phrased in past PR's.

For instance, in the Aug 7th PR:

""We are entering the second half of 2017 with our strongest balance sheet to date, which allows the Company to execute the Phase 2 clinical trial in Rett syndrome, for which ANAVEX™ 2-73 has been granted Orphan Drug Designation by the FDA, as well as the Phase 2/3 clinical trial in Alzheimer’s disease and the Phase 2 clinical trial in Parkinson’s disease,” said Christopher U. Missling"

They very carefully laid out their plans in this PR. Seems funny to me that they would mash it all together today in the PR.

Could be nothing, but perhaps not.

Keep your eyes open for new developments!!